Phospholemman (FXYD1) raises the affinity of the human α1β1 isoform of Na,K-ATPase for Na ions
- PMID: 21449573
- DOI: 10.1021/bi2001714
Phospholemman (FXYD1) raises the affinity of the human α1β1 isoform of Na,K-ATPase for Na ions
Abstract
The human α(1)/His(10)-β(1) isoform of the Na,K-ATPase has been expressed in Pichia pastoris, solubilized in n-dodecyl-β-maltoside, and purified by metal chelate chromatography. The α(1)β(1) complex spontaneously associates in vitro with the detergent-solubilized purified human FXYD1 (phospholemman) expressed in Escherichia coli. It has been confirmed that FXYD1 spontaneously associates in vitro with the α(1)/His(10)-β(1) complex and stabilizes it in an active mode. The functional properties of the α(1)/His(10)-β(1) and α(1)/His(10)-β(1)/FXYD1 complexes have been investigated by fluorescence methods. The electrochromic dye RH421 which monitors binding to and release of ions from the binding sites has been applied in equilibrium titration experiments to determine ion binding affinities and revealed that FXYD1 induces an ∼30% increase of the Na(+)-binding affinity in both the E(1) and P-E(2) conformations. By contrast, it does not affect the affinities for K(+) and Rb(+) ions. Phosphorylation induced partial reactions of the enzyme have been studied as backdoor phosphorylation by inorganic phosphate and in kinetic experiments with caged ATP in order to evaluate the ATP-binding affinity and the time constant of the conformational transition, Na(3)E(1)-P → P-E(2)Na(3). No significant differences with or without FXYD1 could be detected. Rate constants of the conformational transitions Rb(2)E(1) → E(2)(Rb(2)) and E(2)(Rb(2)) → Na(3)E(1), investigated with fluorescein-labeled Na,K-ATPase, showed only minor or no effects of FXYD1, respectively. The conclusion from all these experiments is that FXYD1 raises the binding affinity of α(1)β(1) for Na ions, presumably at the third Na-selective binding site. In whole cell expression studies FXYD1 reduces the apparent affinity for Na ions. Possible reasons for the difference from this study using the purified recombinant Na,K-ATPase are discussed.
Similar articles
-
Molecular Mechanisms and Kinetic Effects of FXYD1 and Phosphomimetic Mutants on Purified Human Na,K-ATPase.J Biol Chem. 2015 Nov 27;290(48):28746-59. doi: 10.1074/jbc.M115.687913. Epub 2015 Oct 1. J Biol Chem. 2015. PMID: 26429909 Free PMC article.
-
Purification of the human alpha2 Isoform of Na,K-ATPase expressed in Pichia pastoris. Stabilization by lipids and FXYD1.Biochemistry. 2007 Dec 25;46(51):14937-50. doi: 10.1021/bi701812c. Epub 2007 Dec 4. Biochemistry. 2007. PMID: 18052210
-
Functional interactions of phospholemman (PLM) (FXYD1) with Na+,K+-ATPase. Purification of alpha1/beta1/PLM complexes expressed in Pichia pastoris.J Biol Chem. 2006 Jun 9;281(23):15790-9. doi: 10.1074/jbc.M601993200. Epub 2006 Apr 11. J Biol Chem. 2006. PMID: 16608841
-
Partial reactions of the Na,K-ATPase: kinetic analysis and transport properties.Acta Physiol Scand Suppl. 1998 Aug;643:235-45. Acta Physiol Scand Suppl. 1998. PMID: 9789566 Review.
-
Splice variants of the gamma subunit (FXYD2) and their significance in regulation of the Na, K-ATPase in kidney.J Bioenerg Biomembr. 2005 Dec;37(6):381-6. doi: 10.1007/s10863-005-9475-y. J Bioenerg Biomembr. 2005. PMID: 16691469 Review.
Cited by
-
Na+/K+-ATPase Revisited: On Its Mechanism of Action, Role in Cancer, and Activity Modulation.Molecules. 2021 Mar 28;26(7):1905. doi: 10.3390/molecules26071905. Molecules. 2021. PMID: 33800655 Free PMC article. Review.
-
Stimulation, inhibition, or stabilization of Na,K-ATPase caused by specific lipid interactions at distinct sites.J Biol Chem. 2015 Feb 20;290(8):4829-4842. doi: 10.1074/jbc.M114.611384. Epub 2014 Dec 22. J Biol Chem. 2015. PMID: 25533463 Free PMC article.
-
A century of exercise physiology: effects of muscle contraction and exercise on skeletal muscle Na+,K+-ATPase, Na+ and K+ ions, and on plasma K+ concentration-historical developments.Eur J Appl Physiol. 2024 Mar;124(3):681-751. doi: 10.1007/s00421-023-05335-9. Epub 2024 Jan 11. Eur J Appl Physiol. 2024. PMID: 38206444 Free PMC article. Review.
-
The inhibitory effect of phospholemman on the sodium pump requires its palmitoylation.J Biol Chem. 2011 Oct 14;286(41):36020-36031. doi: 10.1074/jbc.M111.282145. Epub 2011 Aug 25. J Biol Chem. 2011. PMID: 21868384 Free PMC article.
-
Regulation of the cardiac sodium pump.Cell Mol Life Sci. 2013 Apr;70(8):1357-80. doi: 10.1007/s00018-012-1134-y. Epub 2012 Sep 7. Cell Mol Life Sci. 2013. PMID: 22955490 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous